Cover Image

Benefits of remote real-time side-effect monitoring systems for patients receiving cancer treatment

Sarah Kofoed, Sibilah Breen, Karla Gough, Sanchia Aranda
  • Sarah Kofoed
    Department of Nursing & Supportive Care Research, Peter MacCallum Cancer Centre, East Melbourne, Victoria, Australia
  • Sibilah Breen
    Department of Nursing & Supportive Care Research, Peter MacCallum Cancer Centre, East Melbourne, Victoria; Department of Nursing, Melbourne School of Health Sciences, University of Melbourne, Victoria, Australia | sibilah.breen@petermac.org
  • Karla Gough
    Department of Nursing & Supportive Care Research, Peter MacCallum Cancer Centre, East Melbourne, Victoria, Australia
  • Sanchia Aranda
    Department of Nursing & Supportive Care Research, Peter MacCallum Cancer Centre, East Melbourne, Victoria; Department of Nursing, Melbourne School of Health Sciences, University of Melbourne, Victoria; Division of Cancer Services and Information, Cancer Institute NSW, Alexandria, NSW, Australia

Abstract

In Australia, the incidence of cancer diagnoses is rising along with an aging population. Cancer treatments, such as chemotherapy, are increasingly being provided in the ambulatory care setting. Cancer treatments are commonly associated with distressing and serious sideeffects and patients often struggle to manage these themselves without specialized real-time support. Unlike chronic disease populations, few systems for the remote real-time monitoring of cancer patients have been reported. However, several prototype systems have been developed and have received favorable reports. This review aimed to identify and detail systems that reported statistical analyses of changes in patient clinical outcomes, health care system usage or health economic analyses. Five papers were identified that met these criteria. There was wide variation in the design of the monitoring systems in terms of data input method, clinician alerting and response, groups of patients targeted and clinical outcomes measured. The majority of studies had significant methodological weaknesses. These included no control group comparisons, small sample sizes, poor documentation of clinical interventions or measures of adherence to the monitoring systems. In spite of the limitations, promising results emerged in terms of improved clinical outcomes (e.g. pain, depression, fatigue). Health care system usage was assessed in two papers with inconsistent results. No studies included health economic analyses. The diversity in systems described, outcomes measured and methodological issues all limited between-study comparisons. Given the acceptability of remote monitoring and the promising outcomes from the few studies analyzing patient or health care system outcomes, future research is needed to rigorously trial these systems to enable greater patient support and safety in the ambulatory setting.

Keywords

cancer, chemotherapy, toxicities, remote monitoring.

Full Text

PDF
HTML
Submitted: 2012-02-17 05:50:07
Published: 2012-06-05 16:52:29
Search for citations in Google Scholar
Related articles: Google Scholar
Abstract views:
5770

Views:
PDF
681
HTML
509

Article Metrics

Metrics Loading ...

Metrics powered by PLOS ALM


Copyright (c) 2012 Sarah Kofoed, Sibilah Breen, Karla Gough, Sanchia Aranda

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
 
© PAGEPress 2008-2017     -     PAGEPress is a registered trademark property of PAGEPress srl, Italy.     -     VAT: IT02125780185